Details for 2015746399
Up to date per 22.05.2026
Actions
Details for 2015746399
Granted/Registered
European Patent
14.12.2016 A
28.08.2024 B1
04.02.2014
US
201461935833 P
C12N 5/0783 20100101AFI20240605BHEP
Owner
The United States of America, as Represented by The Secretary, Department of Health and Human ServicesOffice of Technology Transfer National Institutes of Health 6701 Rockledge Drive Suite 700, MSC 7788 Bethesda, Maryland 20892-7788US
Kite Pharma, Inc.2400 Broadway Santa Monica, CA 90404US
Representative
Representative
SONN Patentanwälte GmbH & Co KGRiemergasse 14/281010 WienAT
SONN Patentanwälte GmbH & Co KGRiemergasse 14/281010 WienAT
Inventor
BETTER, Marc2225 Colorado Avenue Santa Monica, California 90404US
FELDMAN, Steven A.National Cancer Institute 10, Center Dr. Bethesda, Maryland 20892-1201US
ROSENBERG, Steven A.National Cancer Institute 10, Center Dr. Bethesda, Maryland 20892-1201US
Information about Fees